| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0090-4295(99)00295-2 |
| P8608 | Fatcat ID | release_q2z6macfbfexfdbmwh2vpdaguu |
| P698 | PubMed publication ID | 10604717 |
| P2093 | author name string | Atkinson G | |
| Hall SJ | |||
| P2860 | cites work | Bystander killing of cancer cells by herpes simplex virus thymidine kinase gene is mediated by connexins | Q24568170 |
| Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation | Q24642901 | ||
| The "bystander effect": association of U-87 cell death with ganciclovir-mediated apoptosis of nearby cells and lack of effect in athymic mice. | Q34294662 | ||
| Gene therapy for brain tumors: regression of experimental gliomas by adenovirus-mediated gene transfer in vivo | Q35152561 | ||
| Effects of combination endocrine treatment on normal prostate, prostatic intraepithelial neoplasia, and prostatic adenocarcinoma | Q39637304 | ||
| Cooperative therapeutic effects of androgen ablation and adenovirus-mediated herpes simplex virus thymidine kinase gene and ganciclovir therapy in experimental prostate cancer | Q40967021 | ||
| Adenovirus-mediated herpes simplex virus thymidine kinase gene and ganciclovir therapy leads to systemic activity against spontaneous and induced metastasis in an orthotopic mouse model of prostate cancer | Q41133838 | ||
| Prostate cancer gene therapy: herpes simplex virus thymidine kinase gene transduction followed by ganciclovir in mouse and human prostate cancer models | Q41220903 | ||
| External beam radiotherapy for stage T1/T2 prostate cancer: how does it stack up? | Q41718410 | ||
| Progression to androgen insensitivity in a novel in vitro mouse model for prostate cancer | Q42803485 | ||
| Retrovirus-mediated herpes simplex virus thymidine kinase gene transduction renders human thyroid carcinoma cell lines sensitive to ganciclovir and radiation in vitro and in vivo | Q44651280 | ||
| Early Prostate Cancer: The National Results of Radiation Treatment from the Patterns of Care and Radiation Therapy Oncology Group Studies With Prospects for Improvement with Conformal Radiation and Adjuvant Androgen Deprivation | Q45047282 | ||
| Effect of local tumor control on distant metastasis and survival in prostatic adenocarcinoma | Q45075604 | ||
| Selective enhancement of radiation response of herpes simplex virus thymidine kinase transduced 9L gliosarcoma cells in vitro and in vivo by antiviral agents | Q45788346 | ||
| Preferential radiosensitization of 9L glioma cells transduced with HSV-tk gene by acyclovir | Q45882352 | ||
| Multistage carcinogenesis induced by ras and myc oncogenes in a reconstituted organ. | Q53516187 | ||
| Supraadditive apoptotic response of R3327-G rat prostate tumors to androgen ablation and radiation. | Q54699619 | ||
| Apoptosis and mitotic cell death: their relative contributions to normal-tissue and tumour radiation response | Q59139048 | ||
| Improved Survival in Patients with Locally Advanced Prostate Cancer Treated with Radiotherapy and Goserelin | Q59364974 | ||
| Phase II Radiation Therapy Oncology Group study of hormonal cytoreduction with flutamide and Zoladex in locally advanced carcinoma of the prostate treated with definitive radiotherapy | Q68432327 | ||
| Enhancement of radiation effects by acyclovir | Q69619894 | ||
| Radical radiation therapy in the management of prostatic adenocarcinoma: the initial prostate specific antigen value as a predictor of treatment outcome | Q71609910 | ||
| Neoadjuvant hormonal therapy improves the therapeutic ratio in patients with bulky prostatic cancer treated with three-dimensional conformal radiation therapy | Q72081134 | ||
| Phase III trial of androgen suppression using goserelin in unfavorable-prognosis carcinoma of the prostate treated with definitive radiotherapy: report of Radiation Therapy Oncology Group Protocol 85-31 | Q73132167 | ||
| Beneficial effect of combination hormonal therapy administered prior and following external beam radiation therapy in localized prostate cancer | Q73153252 | ||
| Management of unfavorable locoregional prostate carcinoma with radiation and androgen ablation | Q73605938 | ||
| Update on the treatment of prostate cancer with external beam irradiation | Q77476258 | ||
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | gene therapy | Q213901 |
| P304 | page(s) | 1098-1104 | |
| P577 | publication date | 1999-12-01 | |
| P1433 | published in | Urology | Q7900884 |
| P1476 | title | Prodrug activation gene therapy and external beam irradiation in the treatment of prostate cancer | |
| P478 | volume | 54 |
| Q40488102 | Adenovirus-mediated FLT1-targeted proapoptotic gene therapy of human prostate cancer |
| Q33740015 | An experimental study on cervix cancer with combination of HSV-TK/GCV suicide gene therapy system and 60Co radiotherapy |
| Q45856165 | Biological response determinants in HSV-tk + ganciclovir gene therapy for prostate cancer |
| Q38047477 | Chapter seven--Cancer treatment with gene therapy and radiation therapy |
| Q45880240 | Combined ionizing radiation and sKDR gene delivery for treatment of prostate carcinomas. |
| Q40183752 | Cooperative therapeutic effects of herpes simplex virus thymidine kinase gene/ganciclovir system and chemotherapeutic agents on prostate cancer in vitro |
| Q43796443 | Enhanced therapeutic effect of multiple injections of HSV-TK + GCV gene therapy in combination with ionizing radiation in a mouse mammary tumor model |
| Q36349678 | Gene delivery and gene therapy of prostate cancer |
| Q35609061 | Gene therapy for carcinoma of the breast |
| Q74319886 | Gene therapy for prostate cancer |
| Q74362616 | Gene therapy for prostate cancer |
| Q39751688 | In vivo characterization of horseradish peroxidase with indole-3-acetic acid and 5-bromoindole-3-acetic acid for gene therapy of cancer |
| Q40595026 | Phase I/II trial evaluating combined radiotherapy and in situ gene therapy with or without hormonal therapy in the treatment of prostate cancer--a preliminary report |
| Q24792836 | Prodrugs for Gene-Directed Enzyme-Prodrug Therapy (Suicide Gene Therapy) |
| Q64378233 | Prostate cancer gene therapy |
| Q40643017 | Relative promoter strengths in four human prostate cancer cell lines evaluated by particle bombardment-mediated gene transfer |
Search more.